User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

1599

Interactions with Platform & by Email *

INTERACTIONS

288

Unique # Participated *

PARTICIPANTS

64

Responses Validated *

VALIDATIONS

14

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Specialty Enzymes: Indispensable to the Pharmaceutical Industry.....II-1 1$100
   Table 1: Global Market for Pharmaceutical/ Diagnostics Enzymes by Application (2015E): Percentage Breakdown for Diagnostics, Digestive, Enzyme Replacement Therapy, Thrombolytic, and Others (includes corresponding Graph/Chart).....II-2
Outlook.....II-2
2$350
   Developed Regions Dominate Global Demand.....II-4
Table 2: Global Market for Specialty Enzymes by Geographic Region/Country (2015E): Percentage Breakdown of Value Sales for Asia-Pacific, Canada, Europe, Japan, Latin America, the US, and Rest of World (includes corresponding Graph/Chart).....II-4
1$350
   Table 3: Healthcare Spending as a Percentage of GDP by Geographic Region - North America, Western Europe, Latin America, Eastern Europe, Asia, and Middle East & Africa: 2015E (includes corresponding Graph/Chart).....II-5

Table 4: Per-Capita Healthcare Expenditure in Select Regions - The US, EU, Asia, and China: 2014E (includes corresponding Graph/Chart).....II-5
1$350
   Robust Demand from the Pharmaceutical Industry: A Strong Growth Driver.....II-6 1$100
   Table 5: Global Market for Pharmaceuticals by Medication Class (2014): Percentage Breakdown of Value Sales for Anti-Infectives, Biologicals, Cardiovascular Drugs, Central Nervous System Drugs, Dermatological Agents, Gastrointestinal Agents, Hormones and Metabolic Agents, Nutritional Preparations, Ophthalmic Agents, Respiration Medications, and Other Medications (includes corresponding Graph/Chart).....II-71$350
   Pharmaceutical Medication Class and Respective Growth Drivers.....II-81$100
   Some Important Specialty Enzymes and their Therapeutic Uses.....II-9
Nattokinase Lowers Risk of Blood Clots.....II-9
1$100
   Seaprose-S: Effective in Break-up of Mucus.....II-10
Papain and Bromelain: Anti-Inflammatory Agents.....II-10
Serratiopeptidase: Anti-Inflammation and Analgesic Agent.....II-10
Some Important Therapeutic Enzymes and their Source.....II-10
1$100
   Sources of Therapeutic Enzymes by Type: Listing of Source and Enzyme Derived for
  Animal Sources, Plant Sources, and Microbial Sources.....II-11
Specialty Enzymes Reduce Pharmaceutical Production Costs.....II-11
1$100
   Rising Prominence in Disease Diagnosis Expands Market Opportunities.....II-12
Focus on Preventive Medicine Spurs Growth in the Diagnostic Enzymes Market.....II-12
1$100
   Expanding Home Glucose Testing Market Bodes Well for Enzymes in Diagnostic
  Applications.....II-13
1$100
   Increasing Diabetes Incidence Worldwide: Key Opportunity Indicator.....II-14
Table 6: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart).....II-14
Specialty Enzyme Advancements: Spearheading Growth.....II-14
1$350
   University of Pittsburgh Discovers the First Halogenations Enzyme.....II-15
Growing Significance of Systemic Enzymes in Human Health Strengthens Market
  Prospects.....II-15
1$100
   Systemic Enzymes Aids in Effective Pain and Inflammation Management.....II-161$100
   Serrapeptase Enzyme: An Anti-Edemic and Anti-Inflammatory Agent.....II-17
EXCLZYME: An Apt Replacement for NSAIDS?.....II-17
1$100
   Systemic Enzyme Therapy Relieve Painful Effects of Cancer Therapies.....II-18
Systemic Enzymes for Nutritional Support throughout the Body.....II-18
1$100
   Regenerative Medicine: A Niche Market Beckons.....II-19
Increasing Consumption in Health Supplements Augurs Well for the Market.....II-19
1$100
   Rising Adoption of Enzyme Supplements Spurs Product Innovation.....II-20
Spiraling Healthcare Costs: An Important Opportunity Indicator for Supplemental
  Enzymes.....II-20
1$100
   Role of Specialty Enzymes in Supporting Cardiovascular Health Boosts Market
  Prospects.....II-21
Cardiovascular Disease (CVD) Facts and Figures.....II-21
1$100
   Key CVD Statistics.....II-22
Table 7: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart).....II-22

Table 8: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart).....II-22
1$350
   Specialty Enzymes in Alzheimer’s, Parkinson’s, and Cancer Therapies Benefit Market
  Expansion.....II-23
Cancer Cases: Important Opportunity Indicator.....II-23
Table 9: Worldwide Incidence of Cancer (2013, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart).....II-23
1$350
   Table 10: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart).....II-24
Enzyme Replacement Therapies for Lysosomal Storage Diseases (LSDs) Holds
  Promise.....II-24
1$350
   Aging Population Spurs Demand for Pharmaceutical and Diagnostic Enzymes.....II-25 1$100
   Table 11: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart).....II-261$350
   Table 12: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....II-27
Specialty Enzyme as Biocatalysts in the Manufacture of Drugs and Fine
  Chemicals.....II-27
1$350
   Focus on Green Manufacturing Processes Drive Demand for Biocatalysts.....II-281$100
   Advancements in Enzyme Manufacturing Processes Aids Growth.....II-29
Immobilization of Enzymes Opens up a World of Opportunities.....II-29
1$100
   European Food Enzymes Industry Shifts Focus towards Specialty Enzymes from Commodity
  Enzymes.....II-30
1$100
   Strong Research Activity Bodes Well for Research and Biotechnology Enzymes.....II-31
Surging Demand for Eco-Friendly Enzymes Spurs R&D.....II-31
1$100
   Developing Countries: Potential Laden Markets.....II-32
Table 13: Global Specialty Enzymes Market - Geographic Regions Ranked by CAGR for 2014-2020: Asia-Pacific, Latin America, the US, Canada, Europe, Japan, and Rest of World (includes corresponding Graph/Chart).....II-32
1$350
   Manufacturers in Developed Countries Move Production Base to Developing
  Markets.....II-33
Alkaline Phosphatase (ALP): A Key Diagnostic & Research Enzyme.....II-33
Diagnostics.....II-33
1$100
   As a Diagnostic Enzyme in the Dairy Industry.....II-34
Research.....II-34
1$100
   Regulatory Issues to Ensure Safety of Enzyme Usage.....II-35
CRN & ETA Issue Guideline for Enzyme Supplements.....II-35
1$100
   Enzymes: An Introduction.....II-36
A Brief History.....II-36
1$100
   Categorization of Enzymes.....II-37
Advantages of Enzymes over Chemical Catalysts.....II-37
1$100
   Classification of Enzymes Based on Application.....II-38
Industrial Enzymes.....II-38
Specialty Enzymes.....II-38
Proteases.....II-38
1$100
   Polymerases.....II-39
Carbohydrases.....II-39
1$100
   Other Specialty Enzymes.....II-40
Nucleases.....II-40
Lipases.....II-40
1$100
   Catalases.....II-41
Oxidase.....II-41
Laccases.....II-41
Phytases.....II-41
1$100
   GingisKHAN, a New Enzyme Product, Launched by Genovis AB.....II-42
BioMarin Secures FDA Approval for VimiZim™.....II-42
Specialty Enzymes Unveils FlavorSEB L Enzyme Series for Pet Food Processing.....II-42
Enzymedica Unveils Digest Gold with ATProacents.....II-42
Deerland Enzymes Unveils New Enzyme-based Technologies.....II-42
Sekisui Enzymes Introduces New Thermostable Enzyme Range.....II-42
1$100
   Codexis Launches Improved CodeXyme®.....II-43
Deerland Enzymes Introduces New ThioZymeYD Dietary Supplement.....II-43
Sekisui Enzymes Introduces New ß-Lactamase Enzyme.....II-43
1$100
   Novozymes and China National Pharmaceutical Foreign Trade Enter Distribution
  Deal.....II-44
GSK & Codexis Enter Technology Licensing Agreement.....II-44
Connell Brothers Takes Over Enzyme Solutions.....II-44
Codexis Enters Product Development Deal with Purolite.....II-44
Sekisui Diagnostics Announces New Headquarters in Massachusetts.....II-44
Specialty Enzymes Expands Enzyme Products Manufacturing Capacity.....II-44
1$100
   Cornerstone Therapeutics Inks Agreement with Digestive Care.....II-45
Codexis Extends Process and Catalyst Development Agreement with Merck.....II-45
GENETRIX Inks Licensing Agreement with QIAGEN.....II-45
Anil Bioplus to Establish Production Unit at Halol.....II-45
1$100
   Advanced Enzymes Technologies Limited (India).....II-46
Advanced Vital Enzymes Ltd. (India).....II-46
1$100
   AST Enzymes (US).....II-47
Specialty Enzymes & Biotechnologies Co. (US).....II-47
Affymetrix, Inc. (US).....II-47
1$100
   Amano Enzyme, Inc. (Japan).....II-48
Biocatalysts Ltd. (UK).....II-48
BBI Solutions (UK).....II-48
1$100
   Chr. Hansen A/S (Denmark).....II-49
Codexis, Inc. (US).....II-49
F. Hoffmann-La Roche Ltd. (Switzerland).....II-49
1$100
   Genzyme Corporation (US).....II-50
Life Technologies (US).....II-50
1$100
   Meteoric Life Sciences (India).....II-51
Nagase & Co. Ltd (Japan).....II-51
National Enzyme Company (US).....II-51
1$100
   The Soufflet Group (France).....II-521$100
   Table 14: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-531$350
   Table 15: World Historic Review for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-541$350
   Table 16: World 14-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-551$350
   Specialty Enzymes Market by Product Segment.....II-56
Table 17: World Recent Past, Current & Future Analysis for Proteases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-56
1$350
   Table 18: World Historic Review for Proteases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-571$350
   Table 19: World 14-Year Perspective for Proteases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-581$350
   Table 20: World Recent Past, Current & Future Analysis for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-591$350
   Table 21: World Historic Review for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-601$350
   Table 22: World 14-Year Perspective for Polymerases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-611$350
   Table 23: World Recent Past, Current & Future Analysis for Carbohydrases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-621$350
   Table 24: World Historic Review for Carbohydrases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-631$350
   Table 25: World 14-Year Perspective for Carbohydrases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-641$350
   Table 26: World Recent Past, Current & Future Analysis for Other Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-651$350
   Table 27: World Historic Review for Other Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-661$350
   Table 28: World 14-Year Perspective for Other Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-671$350
   Specialty Enzymes Market by End-Use Segment.....II-68
Table 29: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-68
1$350
   Table 30: World Historic Review for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-691$350
   Table 31: World 14-Year Perspective for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-701$350
   Table 32: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-711$350
   Table 33: World Historic Review for Specialty Enzymes Consumption in Research/ Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-721$350
   Table 34: World 14-Year Perspective for Specialty Enzymes Consumption in Research/ Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-731$350
   Table 35: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-741$350
   Table 36: World Historic Review for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-751$350
   Table 37: World 14-Year Perspective for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-761$350
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
Specialty Enzymes Market Overview.....III-1
1$75
   Specialty and Industrial Enzymes: Gradual Narrowing of Differences.....III-2
Discovery of the First Halogenations Enzyme: Market Implications.....III-2
Enzymes for Food Analysis and Testing: Key Challenges Faced.....III-2
1$75
   Aging Population Spurs Demand for Therapeutic and Diagnostic Enzymes.....III-3
Table 38: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-3
1$200
   CRN & ETA Issue Guideline for Enzyme Supplements.....III-4
Product Launches.....III-4
1$75
   Recent Industry Activity.....III-51$75
   Key Players.....III-63$225
   B. Market Analytics.....III-9
Table 39: US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-9
1$200
   Table 40: US Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-101$200
   Table 41: US 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-111$200
   Table 42: US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-121$200
   Table 43: US Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-131$200
   Table 44: US 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-141$200
   A. Market Analysis.....III-15
Current and Future Analysis.....III-15
1$75
   B. Market Analytics.....III-16
Table 45: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-16
1$200
   Table 46: Canadian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-171$200
   Table 47: Canadian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-181$200
   Table 48: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-191$200
   Table 49: Canadian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-201$200
   Table 50: Canadian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-211$200
   A. Market Analysis.....III-22
Current and Future Analysis.....III-22
Expanding Aging Population Offers Opportunities for Pharmaceutical Enzymes.....III-22
Table 51: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-22
1$200
   Key Players.....III-231$75
   B. Market Analytics.....III-24
Table 52: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-24
1$200
   Table 53: Japanese Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-251$200
   Table 54: Japanese 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-261$200
   Table 55: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-271$200
   Table 56: Japanese Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-281$200
   Table 57: Japanese 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-291$200
   A. Market Analysis.....III-30
Current and Future Analysis.....III-30
Accelerating Trend towards Environmentally Friendly Enzymes.....III-30
Enzymes for Research and Biotechnology to Report Faster Gains.....III-30
1$75
   European Food Enzymes Industry Shifts Focus towards Specialty Enzymes from Commodity
  Enzymes.....III-31
Aging Population Boosts Demand for Pharmaceutical and Diagnostic Enzymes.....III-31
1$75
   Table 58: European Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-321$200
   Table 59: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart).....III-331$200
   B. Market Analytics.....III-34
Table 60: European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   Table 61: European Historic Review for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-351$200
   Table 62: European 14-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-361$200
   Table 63: European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-371$200
   Table 64: European Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-381$200
   Table 65: European 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-391$200
   Table 66: European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-401$200
   Table 67: European Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-411$200
   Table 68: European 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-421$200
   A. Market Analysis.....III-43
Current and Future Analysis.....III-43
The Soufflet Group – A Key Regional Player.....III-43
1$75
   B. Market Analytics.....III-44
Table 69: French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-44
1$200
   Table 70: French Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-451$200
   Table 71: French 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-461$200
   Table 72: French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-471$200
   Table 73: French Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-481$200
   Table 74: French 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-491$200
   A. Market Analysis.....III-50
Current and Future Analysis.....III-50
1$75
   B. Market Analytics.....III-51
Table 75: German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-51
1$200
   Table 76: German Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-521$200
   Table 77: German 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-531$200
   Table 78: German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-541$200
   Table 79: German Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-551$200
   Table 80: German 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-561$200
   A. Market Analysis.....III-57
Current and Future Analysis.....III-57
1$75
   B. Market Analytics.....III-58
Table 81: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-58
1$200
   Table 82: Italian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-591$200
   Table 83: Italian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-601$200
   Table 84: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-611$200
   Table 85: Italian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-621$200
   Table 86: Italian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-631$200
   A. Market Analysis.....III-64
Current and Future Analysis.....III-64
Product Launches.....III-64
Key Players.....III-64
2$150
   B. Market Analytics.....III-66
Table 87: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-66
1$200
   Table 88: UK Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-671$200
   Table 89: UK 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-681$200
   Table 90: UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-691$200
   Table 91: UK Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-701$200
   Table 92: UK 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-711$200
   A. Market Analysis.....III-72
Current and Future Analysis.....III-72
Recent Industry Activity.....III-72
1$75
   B. Market Analytics.....III-73
Table 93: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-73
1$200
   Table 94: Spanish Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-741$200
   Table 95: Spanish 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-751$200
   Table 96: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-761$200
   Table 97: Spanish Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-771$200
   Table 98: Spanish 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-781$200
   A. Market Analysis.....III-79
Current and Future Analysis.....III-79
1$75
   B. Market Analytics.....III-80
Table 99: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-80
1$200
   Table 100: Russian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-811$200
   Table 101: Russian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-821$200
   Table 102: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-831$200
   Table 103: Russian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-841$200
   Table 104: Russian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-851$200
   A. Market Analysis.....III-86
Current and Future Analysis.....III-86
Product Launch.....III-86
Key Players.....III-86
2$150
   B. Market Analytics.....III-88
Table 105: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-88
1$200
   Table 106: Rest of Europe Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-891$200
   Table 107: Rest of Europe 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-901$200
   Table 108: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-911$200
   Table 109: Rest of Europe Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-921$200
   Table 110: Rest of Europe 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-931$200
   A. Market Analysis.....III-94
Current and Future Analysis.....III-94
Specialty Enzymes at Par with Industrial Enzymes in APAC.....III-94
Asian Countries: Strong Markets with Huge Untapped Potential.....III-94
1$75
   Table 111: Global Market for Specialty Enzymes (2014-2020): Ranked by CAGR for Asia-Pacific, Latin America, US, Canada, Europe, Japan, and Rest of World (includes corresponding Graph/Chart).....III-95

Table 112: Asian Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-95
1$200
   India & China: Potential Laden Markets for Pharma and Diagnostic Enzymes.....III-96
Table 113: China and India Lead Global Population (July 2013): China and India’s Huge Population Vis-a-vis Other Countries’ Population (in Million) by Age Group (includes corresponding Graph/Chart).....III-96
1$200
   Manufacturers in Developed Countries Move Production Base to Developing
  Markets.....III-97
1$75
   B. Market Analytics.....III-98
Table 114: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - China, India, South Korea and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-98
1$200
   Table 115: Asia-Pacific Historic Review for Specialty Enzymes by Geographic Region - China, India, South Korea and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-991$200
   Table 116: Asia-Pacific 14-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for China, India, South Korea and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1001$200
   Table 117: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1011$200
   Table 118: Asia-Pacific Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1021$200
   Table 119: Asia-Pacific 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1031$200
   Table 120: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1041$200
   Table 121: Asia-Pacific Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1051$200
   Table 122: Asia-Pacific 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1061$200
   A. Market Analysis.....III-107
Current and Future Analysis.....III-107
Chinese Enzyme Demand by End-Use.....III-107
Table 123: Chinese Enzyme Market by End-Use Sector (2014): Percentage Breakdown of Value Sales for Industrial (Animal Feed, Cleaning Products, Ethanol Production, Food & Beverage, and Other Industrial) and Specialty (includes corresponding Graph/Chart).....III-107
1$200
   Enzyme Demand by Enzyme Type.....III-108
Table 124: Chinese Enzyme Market by Type (2014): Percentage Breakdown of Value Sales for Carbohydrases (Amylases and Other Carbohydrases), Lipases, Polymerases & Nucleases, Proteases, and Other Enzymes (includes corresponding Graph/Chart).....III-108
Strategic Corporate Development.....III-108
1$200
   B. Market Analytics.....III-109
Table 125: Chinese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-109
1$200
   Table 126: Chinese Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1101$200
   Table 127: Chinese 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1111$200
   Table 128: Chinese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1121$200
   Table 129: Chinese Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1131$200
   Table 130: Chinese 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1141$200
   A. Market Analysis.....III-115
Current and Future Analysis.....III-115
India: One of the Fastest Growing Enzymes Market.....III-115
Recent Industry Activity.....III-115
1$75
   Key Players.....III-1161$75
   B. Market Analytics.....III-117
Table 131: Indian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-117
1$200
   Table 132: Indian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1181$200
   Table 133: Indian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1191$200
   Table 134: Indian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1201$200
   Table 135: Indian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1211$200
   Table 136: Indian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1221$200
   A. Market Analysis.....III-123
Current and Future Analysis.....III-123
1$75
   B. Market Analytics.....III-124
Table 137: South Korean Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-124
1$200
   Table 138: South Korean Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1251$200
   Table 139: South Korean 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1261$200
   Table 140: South Korean Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1271$200
   Table 141: South Korean Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1281$200
   Table 142: South Korean 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1291$200
   A. Market Analysis.....III-130
Current and Future Analysis.....III-130
Strategic Corporate Development.....III-130
1$75
   B. Market Analytics.....III-131
Table 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-131
1$200
   Table 144: Rest of Asia-Pacific Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1321$200
   Table 145: Rest of Asia-Pacific 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1331$200
   Table 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1341$200
   Table 147: Rest of Asia-Pacific Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1351$200
   Table 148: Rest of Asia-Pacific 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1361$200
   A. Market Analysis.....III-137
Current and Future Analysis.....III-137
B. Market Analytics.....III-137
Table 149: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-137
1$200
   Table 150: Latin American Historic Review for Specialty Enzymes by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1381$200
   Table 151: Latin American 14-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1391$200
   Table 152: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1401$200
   Table 153: Latin American Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1411$200
   Table 154: Latin American 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1421$200
   Table 155: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1431$200
   Table 156: Latin American Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1441$200
   Table 157: Latin American 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1451$200
   A. Market Analysis.....III-146
Current and Future Analysis.....III-146
1$75
   B. Market Analytics.....III-147
Table 158: Brazilian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-147
1$200
   Table 159: Brazilian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1481$200
   Table 160: Brazilian 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1491$200
   Table 161: Brazilian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1501$200
   Table 162: Brazilian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1511$200
   Table 163: Brazilian 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1521$200
   A. Market Analysis.....III-153
Current and Future Analysis.....III-153
1$75
   B. Market Analytics.....III-154
Table 164: Rest of Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-154
1$200
   Table 165: Rest of Latin American Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1551$200
   Table 166: Rest of Latin American 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1561$200
   Table 167: Rest of Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1571$200
   Table 168: Rest of Latin American Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1581$200
   Table 169: Rest of Latin American 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1591$200
   A. Market Analysis.....III-160
Current and Future Analysis.....III-160
1$75
   B. Market Analytics.....III-161
Table 170: Rest of the World Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-161
1$200
   Table 171: Rest of the World Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1621$200
   Table 172: Rest of the World 14-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1631$200
   Table 173: Rest of the World Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1641$200
   Table 174: Rest of the World Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1651$200
   Table 175: Rest of the World 14-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1661$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com